Description
SWOT ANALYSIS OF HOSPIRA
Hospira
Parent Company
Hospira
Category
Health care
Sector
Medical Equipment
Tagline/ Slogan
Advancing Wellness
Broad commitment to healthcare, supported by a wide variety of USP products that help improve the well being of patients around the world
STP
Segment
Injectable drugs and infusion technologies
Target Group
Patients, hospitals
Positioning
Progressive, positive and purposeful approach
SWOT Analysis
1. Portfolio of specialty injectable drugs 2. Strategic acquisitions enabling Hospira to strengthen its business 3. product portfolio includes cardiovascular drugs, analgesics, nesthetics, anti-infectives and oncology injectables 4. broad product portfolio in the specialty injectable pharmaceuticals market helps Hospira in catering to its customer needs besides enhancing the company’s brand image 5. Good market reputation and wide variety of services offered Strength 6. Strong customer centric approach
1. FDA warning letter regarding Rocky Mount manufacturing facility Weakness 2. Intense competition means limited growth in market share
1. Further expansion in emerging countries likely to strengthen Hospira’s manufacturing capacity 2. Launch of generic injectable pharmaceutical products Opportunity 3. Global tie-ups and associations can strengthen brand
1. Dependence on GPO and IDN pricing agreements could affect Threats margins 2. Intense competition could affect the company’s market share
3. Exposure to cost-containment efforts may have a negative impact on the company’s sales and profitability
Competition
1. Baxter International Inc. 2. Pfizer Inc Competitors 3. Terumo Corporation
doc_146368739.docx
SWOT ANALYSIS OF HOSPIRA
Hospira
Parent Company
Hospira
Category
Health care
Sector
Medical Equipment
Tagline/ Slogan
Advancing Wellness
Broad commitment to healthcare, supported by a wide variety of USP products that help improve the well being of patients around the world
STP
Segment
Injectable drugs and infusion technologies
Target Group
Patients, hospitals
Positioning
Progressive, positive and purposeful approach
SWOT Analysis
1. Portfolio of specialty injectable drugs 2. Strategic acquisitions enabling Hospira to strengthen its business 3. product portfolio includes cardiovascular drugs, analgesics, nesthetics, anti-infectives and oncology injectables 4. broad product portfolio in the specialty injectable pharmaceuticals market helps Hospira in catering to its customer needs besides enhancing the company’s brand image 5. Good market reputation and wide variety of services offered Strength 6. Strong customer centric approach
1. FDA warning letter regarding Rocky Mount manufacturing facility Weakness 2. Intense competition means limited growth in market share
1. Further expansion in emerging countries likely to strengthen Hospira’s manufacturing capacity 2. Launch of generic injectable pharmaceutical products Opportunity 3. Global tie-ups and associations can strengthen brand
1. Dependence on GPO and IDN pricing agreements could affect Threats margins 2. Intense competition could affect the company’s market share
3. Exposure to cost-containment efforts may have a negative impact on the company’s sales and profitability
Competition
1. Baxter International Inc. 2. Pfizer Inc Competitors 3. Terumo Corporation
doc_146368739.docx